Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • How are anti-cancer...

    How are anti-cancer drugs available without licence: Court

    Written by Ruby Khatun Khatun Published On 2017-05-16T12:19:24+05:30  |  Updated On 16 May 2017 12:19 PM IST
    How are anti-cancer drugs available without licence: Court

    New Delhi: How are high potency anti-cancer drugs easily available in the market without any licence or bill, putting people's lives at risk, a special court has wondered, expressing serious concern.


    The issue cropped up when a pharma dealer, who did not have a licence and from whom such drugs worth over Rs 50 lakh were allegedly recovered, approached the court seeking anticipatory bail.

    The court said it was matter of serious concern that such drugs were freely available, while also causing loss of revenue to the state exchequer.

    "It is hard to believe that such toxic/high potency anti- cancer drugs can be sold or purchased freely without any license or invoices in the open market, putting the lives of citizens at risk, as also causing loss of revenue to the state exchequer," the court said.

    Special CBI Judge Sanjeev Aggarwal rejected the anticipatory bail plea of Abhinav Pathak, director of Abhinav Biotech Pvt Ltd in Karol Bagh area of central Delhi from whom the drug inspector had allegedly seized drugs, which were stored without the requisite licence for distribution of allopathic drugs.

    "Therefore, the custodial interrogation of the applicant would be required for ascertaining the fact, as to from whom and from where he had procured such huge amounts of anti- cancer drugs without any license and without any invoices, which is a matter of serious concern," the court said.

    The court said that prima facie an offence under the Drugs and Cosmetics Act was attracted towards the accused, which entails a maximum imprisonment of five years and a fine of Rs one lakh or three times the value of the confiscated drugs, whichever is more.

    The drug inspector had carried out the inspection at the pharma dealer's office on May 4. He informed the court that the value of the seized drugs was more than Rs 50 lakh and these costly medicines were used in the treatment of cancer patients.

    Pathak's counsel claimed that he had already applied for licence from the drug authorities and sought anticipatory bail and said he was ready to join the investigation.

    The prosecutor, however, opposed the bail plea.
    Abhinav Biotech Pvt LtdAbhinav Pathakallopathic drugsAnti cancer drugsAnticipatory BailavailablecancerCourtDrugs and Cosmetics ActRs 50 lakhSanjeev Aggarwalwithout licence
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok